LONDON--(BUSINESS WIRE)--The upper respiratory tract infection treatment market is expected to register a CAGR of over 3% during 2020-2024, as per the latest research report by Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios.
Request for Technavio’s market report estimates including pre- and post-COVID-19 impact on upper respiratory tract infection treatment market. Download a Free Sample Report on the impact of COVID-19 pandemic analysis.
Due to the extensive spread of the virus across the globe, the Health Care Industry is anticipated to have Positive impact. The upper respiratory tract infection treatment market will showcase Neutral impact during 2020-2024.
Upper Respiratory Tract Infection Treatment Market 2020-2024: Segmentation
Upper Respiratory Tract Infection Treatment Market is segmented as below:
-
Type
- Antibiotics
- NSAIDs And Nasal Decongestants
- Others
-
Geography
- North America
- Europe
- Asia
- ROW
North America region will account for the highest incremental growth during the forecast period due to the increasing prevalence of upper respiratory tract infections and the rising demand for over-the-counter drugs.
With the surging growth of COVID-19 pandemic, the Health Care market is anticipated to have a Direct impact during the forecast period. View market snapshot before purchasing
Rising incidence and prevalence of upper respiratory tract infections has been an instrumental factor in influencing the growth of upper respiratory tract infection treatment market. Other market drivers include favorable drug pipeline and rising demand for over-the-counter drugs. Technavio offers custom research analysis on the crucial pointers to highlight the impact of COVID-19 on the market across the supply chain.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID 19 market estimates
- Quarterly impact analysis and updates on market estimates
Get more insights about the global trends impacting the future of upper respiratory tract infection treatment market, Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR43396
Upper Respiratory Tract Infection Treatment Market 2020-2024: Vendor Analysis
The market is concentrated, and the degree of concentration will accelerate during the forecast period. Key players in the market have been launching several initiatives and introducing innovative products and services to cater to a larger target audience during the pandemic. Major market participants include AstraZeneca Plc, CSL Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Table of Contents:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Antibiotics - Market size and forecast 2019-2024
- NSAIDs and nasal decongestants - Market size and forecast 2019-2024
- Others - Market size and forecast 2019-2024
- Market opportunity by Type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume driver – demand led growth
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AstraZeneca Plc
- CSL Ltd.
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
